BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31858845)

  • 1. POM121 overexpression is related to a poor prognosis in colorectal cancer.
    Wang T; Sun H; Bao Y; En R; Tian Y; Zhao W; Jia L
    Expert Rev Mol Diagn; 2020 Mar; 20(3):345-353. PubMed ID: 31858845
    [No Abstract]   [Full Text] [Related]  

  • 2. POM121 is a novel marker for predicting the prognosis of laryngeal cancer.
    Zhao R; Tang G; Wang T; Zhang L; Wang W; Zhao Q; Zhao K
    Histol Histopathol; 2020 Nov; 35(11):1285-1293. PubMed ID: 33016327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
    Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
    EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
    Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
    Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TYMS serves as a prognostic indicator to predict the lymph node metastasis in Chinese patients with colorectal cancer.
    Lu Y; Zhuo C; Cui B; Liu Z; Zhou P; Lu Y; Wang B
    Clin Biochem; 2013 Oct; 46(15):1478-83. PubMed ID: 23810585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.
    Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of
    Zhang S; Zheng C; Li D; Bei C; Zhang H; Tian R; Song X; Zhu X; Tan S
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):819-824. PubMed ID: 33296260
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.
    Lv Y; Nie SL; Zhou JM; Liu F; Hu YB; Jiang JR; Li N; Liu JS
    ANZ J Surg; 2017 Dec; 87(12):E251-E255. PubMed ID: 27226356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
    Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
    BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of SOX8 predicts poor prognosis in colorectal cancer: A retrospective study.
    Wang Y; Yang W; Liu T; Bai G; Liu M; Wang W
    Medicine (Baltimore); 2019 Jul; 98(27):e16237. PubMed ID: 31277140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
    Lin MX; Wen ZF; Feng ZY; He D
    Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer.
    Li R; Liu B; Yin H; Sun W; Yin J; Su Q
    J Mol Histol; 2013 Apr; 44(2):183-9. PubMed ID: 23108908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.